Indrayani Biotech Board Meeting on Oct 7 to Approve Unaudited Financial Results

Indrayani Biotech Ltd has announced that its Board of Directors will convene on October 7, 2026. The primary agenda item is the consideration and approval of the company's unaudited financial results for the quarter ended June 30, 2026, covering both standalone and consolidated statements. The meeting will also address the limited review report from the statutory auditors and a proposal for the reconstitution of various board committees. Any other business, with the chair's permission, will also be discussed.